Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma

导出原文传递

翻译打印收藏纠错

作者： Shingo Inaguma ^[1] ; Jerzy Lasota ^[2] ; Zengfeng Wang ^[3] ; Piotr Czapiewski ^[4] ; Renata Langfort ^[5] ; Janusz Rys ^[6] ; Joanna Szpor ^[7] ; Piotr Waloszczyk ^[8] ; Krzysztof Okoń ; Wojciech Biernat ; Hiroshi Ikeda ; David S. Schrump ; Raffit Hassan ; Markku Miettinen

作者单位： Department of Tumor Pathology, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute ^[1] Department of Pathology, Aichi Medical University School of Medicine ^[2] Department of Pathomorphology, Jagiellonian University ^[3] Thoracic and GI Oncology Branch, National Cancer Institute ^[4] Department of Pathology, National Tuberculosis and Lung Diseases Research Institute ^[5] Independent Laboratory of Pathology, Zdunomed ^[6] Laboratory of Pathology, National Cancer Institute ^[7] Department of Pathomorphology, Medical University of Gdansk ^[8]

关键词 ALCAM activated leukocyte cell adhesion molecule (CD166)ALDH1A1 aldehyde dehydrogenase 1A1 (ALDH1)MPM malignant pleural mesothelioma PD-L1 programmed cell death ligand 1 (CD274)SALL4 spalt-like transcription factor 4

发布时间 2019-02-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Human Pathology

2018年71卷

1-7页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma

Human Pathology

相似文献

Human Pathology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma

Human Pathology

相似文献

Human Pathology

相关期刊

检索历史清除